ARS Pharmaceuticals Quote - SPRY

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

11.55

Bid

11.60

Ask

12.40

Volume

974,499

11.55 Day's Range 12.01

5.02 52 Week Range 18.51

Market Cap

1.122B

Previous Close

11.885

Open

11.77

Last Trade

11.9

Last Trade Time

Financial Volume

US$ 11,379,750

VWAP

11.6775

Average Volume (3m)

1,048,341

Shares Outstanding

97,185,475

Dividend Yield

PE Ratio

-21.02

Earnings Per Share (EPS)

-0.56

Revenue

30k

Net Profit

-54.37M

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

ars-pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$11.89. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 5.02 to US$ 18.51.

ARS Pharmaceuticals currently has 97,185,475 shares outstanding. The market capitalization of ARS Pharmaceuticals is US$1.16 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.02.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.78	-13.3533383346	13.33	13.6	11.55	1171652	12.34913247	CS
4	-2.15	-15.6934306569	13.7	14.9	11.55	976036	13.39675575	CS
12	-2.54	-18.0269694819	14.09	18.51	11.55	1048341	14.63898735	CS
26	2.98	34.772462077	8.57	18.51	7.55	1045419	13.25552201	CS
52	6.32	120.841300191	5.23	18.51	5.02	791308	11.64656989	CS
156	6.27	118.75	5.28	18.51	2.55	823041	8.63537234	CS
260	6.27	118.75	5.28	18.51	2.55	823041	8.63537234	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1.02B
GOEVCanoo Inc	US$ 0.118 (7.08%)	388.43M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	259.4M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	222.55M